Changes in the clinical management of 5α-reductase type 2 and 17β-hydroxysteroid dehydrogenase type 3 deficiencies in France.
Estelle BonnetMathias WinterDelphine MalletIngrid PlottonClaire BouvattierMaryse CartignyLaetiti MartinerieMichel PolakAnne BachelotFrédéric HuetSabine BaronMuriel HouangSylvie SoskinAnne LienhardtJérôme BertheratCyril AmourouxAurore BoutyLise DuranteauRémi BessonAlaa El GhoneimiDinane Samara-BoustaniFrançois BecmeurNicolas KalfaFrançoise ParisFrançois MedjkaneAude Brac de la PerrièrePatricia BretonesHervé LejeuneMarc NicolinoPierre MouriquandDaniela-Brindusa GorduzaClaire-Lise GayPublished in: Endocrine connections (2023)
This study showed, over the past two decades, a clear trend toward earlier diagnosis and assignment of affected newborns as males.
Keyphrases